XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
Common Stock [Member]
At The Market Offering Agreement [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
At The Market Offering Agreement [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
At The Market Offering Agreement [Member]
Total
Balance (in shares) at Dec. 31, 2020   8,934,952                    
Balance at Dec. 31, 2020   $ 9,000     $ 259,058,000   $ (253,283,000) $ 16,000 $ 70,000     $ 5,870,000
Stock-based compensation expense         258,000             258,000
Issuance of common stock via at-the-market offering, net (in shares) 2,976,832                      
Issuance of common stock via at-the-market offering, net $ 3,000     $ 6,829,000             $ 6,832,000  
Foreign currency translation gain               1,000       1,000
Net loss             (2,413,000)   (118,000)     (2,531,000)
Balance (in shares) at Mar. 31, 2021   11,911,784                    
Balance at Mar. 31, 2021   $ 12,000     266,145,000   (255,696,000) 17,000 (48,000)     10,430,000
Balance (in shares) at Dec. 31, 2020   8,934,952                    
Balance at Dec. 31, 2020   $ 9,000     259,058,000   (253,283,000) 16,000 70,000     5,870,000
Foreign currency translation gain                       12,000
Balance (in shares) at Sep. 30, 2021   11,911,784                    
Balance at Sep. 30, 2021   $ 12,000     268,336,000   (262,009,000) 28,000 (199,000)     6,168,000
Balance (in shares) at Mar. 31, 2021   11,911,784                    
Balance at Mar. 31, 2021   $ 12,000     266,145,000   (255,696,000) 17,000 (48,000)     10,430,000
Stock-based compensation expense         2,099,000             2,099,000
Foreign currency translation gain               12,000       12,000
Net loss             (4,539,000)   (133,000)     (4,672,000)
Balance (in shares) at Jun. 30, 2021   11,911,784                    
Balance at Jun. 30, 2021   $ 12,000     268,244,000   (260,235,000) 29,000 (181,000)     7,869,000
Stock-based compensation expense         92,000             92,000
Foreign currency translation gain               (1,000)       (1,000)
Net loss             (1,774,000)   (18,000)     (1,792,000)
Balance (in shares) at Sep. 30, 2021   11,911,784                    
Balance at Sep. 30, 2021   $ 12,000     268,336,000   (262,009,000) 28,000 (199,000)     6,168,000
Balance (in shares) at Dec. 31, 2021   11,911,784                    
Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021     $ (10,681,000)     $ 9,739,000       $ (942,000)    
Balance at Dec. 31, 2021   $ 12,000     268,447,000   (264,662,000) 31,000 (431,000)     3,397,000
Stock-based compensation expense         42,000             42,000
Issuance of common stock via at-the-market offering, net (in shares) 918,093                      
Issuance of common stock via at-the-market offering, net $ 1,000     593,000             $ 594,000  
Related party convertible note price reset         213,000             213,000
Foreign currency translation gain               14,000       14,000
Net loss             (1,910,000)   (126,000)     (2,036,000)
Balance (in shares) at Mar. 31, 2022   12,829,877                    
Balance at Mar. 31, 2022   $ 13,000     258,614,000   (256,833,000) 45,000 (557,000)     1,282,000
Balance (in shares) at Dec. 31, 2021   11,911,784                    
Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021     $ (10,681,000)     $ 9,739,000       $ (942,000)    
Balance at Dec. 31, 2021   $ 12,000     268,447,000   (264,662,000) 31,000 (431,000)     3,397,000
Issuance of common stock via at-the-market offering, net (in shares)                     8,857,344  
Related party convertible note price reset                       3,763,000
Foreign currency translation gain                       67,000
Balance (in shares) at Sep. 30, 2022   31,321,362                    
Balance at Sep. 30, 2022   $ 31,000     267,731,000   (262,761,000) 98,000 (833,000)     4,266,000
Balance (in shares) at Mar. 31, 2022   12,829,877                    
Balance at Mar. 31, 2022   $ 13,000     258,614,000   (256,833,000) 45,000 (557,000)     1,282,000
Stock-based compensation expense         72,000             72,000
Issuance of common stock via at-the-market offering, net (in shares) 4,397,329                   1,450,000  
Issuance of common stock via at-the-market offering, net $ 4,000     1,446,000                
Related party convertible note price reset         2,475,000             2,475,000
Foreign currency translation gain               31,000       31,000
Net loss             (2,688,000)   (113,000)     (2,801,000)
Conversion of related party note payable to common stock (in shares)   10,552,234                    
Conversion of related party note payable to common stock   $ 11,000     2,989,000             3,000,000
Balance (in shares) at Jun. 30, 2022   27,779,440                    
Balance at Jun. 30, 2022   $ 28,000     265,596,000   (259,521,000) 76,000 (670,000)     5,509,000
Stock-based compensation expense         70,000             70,000
Issuance of common stock via at-the-market offering, net (in shares) 3,541,922                      
Issuance of common stock via at-the-market offering, net $ 3,000     $ 990,000             $ 993,000  
Related party convertible note price reset         1,075,000             1,075,000
Foreign currency translation gain               22,000       22,000
Net loss             (3,240,000)   (163,000)     (3,403,000)
Balance (in shares) at Sep. 30, 2022   31,321,362                    
Balance at Sep. 30, 2022   $ 31,000     $ 267,731,000   $ (262,761,000) $ 98,000 $ (833,000)     $ 4,266,000